TSLP rs1837253: Understanding Genetic Links to Allergic Traits
The rs1837253 variant is a single nucleotide polymorphism located in the regulatory region of the TSLP gene. It has been widely studied for its statistical associations with allergic conditions, including asthma, atopic dermatitis, and allergic rhinitis.
What each genotype means
Typical allergic disease risk
You carry two copies of the common C allele at rs1837253 upstream of the TSLP gene. Genome-wide association studies associate this baseline genotype with typical reference susceptibility to allergic conditions such as asthma, allergic rhinitis, and eosinophilic esophagitis compared to carriers of the minor T allele. Because evidence strength is limited and allergic phenotypes are polygenic, carrying this genotype does not cause disease on its own.
Carried by approximately 50% to 55% of individuals of European ancestry and is the predominant genotype across most global populations.
Moderately reduced allergic predisposition
You carry one copy of the protective T allele and one copy of the C allele near the TSLP gene. In many large published cohorts, including North American and European asthma studies, carrying one T allele is associated with a modestly lower statistical risk of developing asthma and eosinophilic allergic phenotypes. However, observed associations show sex- and ancestry-specific variability in some studies, reflecting limited and complex clinical evidence.
Carried by approximately 35% to 42% of individuals of European ancestry and roughly 30% to 40% in many Asian and American populations.
Lowered allergic disease predisposition
You carry two copies of the minor T allele upstream of the TSLP gene. In population genetics research, having two copies of the T allele has been linked to the greatest statistical reduction in relative risk for adult-onset asthma, eosinophilic esophagitis, and allergic sensitization compared to the common genotype. However, because overall evidence strength for single-SNP clinical predictability remains limited, this genotype does not guarantee protection against allergic or respiratory conditions.
Carried by approximately 6% to 10% of individuals of European descent and is similarly uncommon across most worldwide ancestral groups.
What is rs1837253?
The variant rs1837253 is a single nucleotide polymorphism (SNP) situated approximately 5.7 kilobases upstream of the transcription start site of the TSLP gene. Because it resides in an intergenic or promoter-adjacent region, researchers hypothesize that it may influence how the TSLP gene is regulated rather than altering the structure of the protein itself. Genetic studies have identified this site as a potential functional locus, as it does not appear to be in strong linkage disequilibrium with other nearby variants, suggesting that the observed associations with health traits may be directly linked to this specific position in the genome.
The Role of the TSLP Gene
The TSLP gene encodes Thymic Stromal Lymphopoietin, a cytokine that plays a critical role in the immune system. TSLP is primarily expressed by epithelial cells in the skin, gut, and lungs, where it acts as a key mediator in the initiation of allergic inflammation. When these cells are exposed to environmental triggers, they release TSLP, which then activates immune cells to promote a type 2 inflammatory response. Because of its central role in signaling, variations that affect the expression levels of TSLP are of significant interest to researchers studying the biological pathways that underlie atopic diseases like asthma and eczema.
Research and Clinical Associations
Research into rs1837253 has consistently shown associations with allergic phenotypes, including asthma, atopic dermatitis, and allergic rhinitis. Studies suggest that the minor allele (T) may be associated with reduced TSLP secretion from nasal epithelial cells compared to the major allele (C). This reduction in protein secretion has led some researchers to describe the T allele as having a 'protective' association against certain allergic traits. However, these findings are complex and often show variability across different ethnic groups and sexes. For instance, some studies have observed stronger associations in male cohorts. It is important to note that while these statistical associations are well-documented in the literature, they do not imply a direct cause-and-effect relationship for any individual, and the evidence strength remains limited in terms of clinical predictability.
Population Frequency
The frequency of the rs1837253 variant varies across different ancestral backgrounds. In many Western European cohorts, the minor allele frequency (MAF) is typically observed between 0.25 and 0.30. Because allele frequencies can differ significantly between populations, the statistical impact of this variant may not be uniform globally. Researchers continue to study these differences to better understand how genetic background influences the risk of allergic disease across diverse human populations.
Interpreting Genetic Information
Genetic variants like rs1837253 provide insights into the biological pathways that may contribute to complex traits, but they are not diagnostic tools. Having a specific genotype does not guarantee the development or absence of any condition, as allergic diseases are influenced by a combination of genetic, environmental, and lifestyle factors. If you are concerned about asthma, allergies, or other inflammatory conditions, it is essential to consult with a healthcare professional. They can provide a proper evaluation based on your clinical history and symptoms. Never use genetic data to make decisions about medication or treatment; always discuss your health concerns and any potential management strategies with your doctor or a qualified pharmacist.
How common is this variant?
The minor allele frequency for rs1837253 is approximately 0.25 to 0.30 in Western European cohorts, though frequencies vary across global populations.
Frequently asked questions
Does having the T allele mean I will not get asthma?
No. While some studies suggest the T allele is associated with a reduced risk of asthma, it does not provide immunity. Asthma is a complex condition influenced by many genetic and environmental factors.
Can I use this SNP to diagnose an allergy?
No. Genetic variants are not diagnostic tests for allergies. Allergies are diagnosed by clinicians through physical exams, medical history, and specific allergy testing.
Is rs1837253 the only gene involved in asthma?
No. Asthma is a polygenic trait, meaning it is influenced by hundreds of different genetic variants across the genome, as well as significant environmental exposures.
Should I change my medication based on my rs1837253 genotype?
No. You should never change your medication or treatment plan based on genetic information. Always consult your doctor or pharmacist before making any changes to your prescribed care.
Sources & further reading
Educational information only, last refreshed 10/18/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1837253?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TSLP
A promoter variant regulating thymic stromal lymphopoietin expression, thereby controlling dendritic cell priming and eosinophilic allergic responses.
Upstream variant of thymic stromal lymphopoietin linked to elevated eosinophil activation and susceptibility to allergic disease.
An upstream promoter variant that alters thymic stromal lymphopoietin expression, mediating susceptibility to allergic rhinitis and childhood asthma.
A well-characterized intergenic polymorphism upstream of TSLP conferring increased risk of eczema-associated food allergy and allergic eosinophilic airway disease.
Functional TSLP locus variant associated with circulating TSLP levels and predisposition to eosinophilic inflammation and asthma.
Upstream variant that alters thymic stromal lymphopoietin expression, increasing susceptibility to eosinophilic inflammation and food allergy.